Home/Publication/Qiming, CDH & Others Double Down on Hep B Treatment
Qiming, CDH & Others Double Down on Hep B Treatment 

30 May 2025

US$ 20.00

Qiming Venture Partners, CDH Venture and Growth Capital, and Genesis Capital have made a follow-on investment in the ......

Price / article: US$20.00
OR existing subscriber
Related Publications

Trident Growth Partners (TGP) and Amicus Capital Partners have co-led the 7.5 bn rupees (US$82 m) funding round of SFO...

Macquarie Asset Management (MAM) is to invest jointly with South Korea’s Gabia Inc 600 bn won (US$420 m) over the ......

Connect With Us

We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.

Rest assured that your email address will not be shared, as we hate spams as much as you do.